Clinical Trial Update: Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing adding insulin glargine versus rosiglitazone as add-on therapy in patients with Type 2 Diabetes Mellitus who failed sulfonylurea and m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Avandia (rosiglitazone)
• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED